The Insomnia Market report highlights market opportunities and competitive scenarios for insomnia on a regional and global basis. Market size estimation and forecasts have been provided based on a unique research design customized to the dynamics of the insomnia market. The insomnia market has been segmented by non-pharmacological therapy (cbti, hypnotherapy), by prescription sleep aids (benzodiazepines, non-benzodiazepines (zaleplon), orexin antagonist), by otc treatment (antihistamine, melatonin, valerian root)). Historic back-drop for insomnia market has been analyzed according to organic and inorganic developments to provide precise market size estimations. Also, key factors impacting the growth of the insomnia market have been identified with potential gravity. Major regions covered in the study include North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and Rest of the World.
Market Segmentation:
By Non-Pharmacological Therapy
• CBTI
• Hypnotherapy
By Prescription Sleep Aids
• Benzodiazepines
• Non-Benzodiazepines
◦ Zaleplon
• Orexin Antagonist
By OTC Treatment
• Antihistamine
• Melatonin
• Valerian Root
By Region:
• North America
◦ North America, by Country
▪ US
▪ Canada
▪ Mexico
◦ North America, by Non-Pharmacological Therapy
◦ North America, by Prescription Sleep Aids
◦ North America, by OTC Treatment
• Western Europe
◦ Western Europe, by Country
▪ Germany
▪ UK
▪ France
▪ Italy
▪ Spain
▪ The Netherlands
▪ Rest of Western Europe
◦ Western Europe, by Non-Pharmacological Therapy
◦ Western Europe, by Prescription Sleep Aids
◦ Western Europe, by OTC Treatment
• Asia Pacific
◦ Asia Pacific, by Country
▪ China
▪ India
▪ Japan
▪ South Korea
▪ Australia
▪ Indonesia
▪ Rest of Asia Pacific
◦ Asia Pacific, by Non-Pharmacological Therapy
◦ Asia Pacific, by Prescription Sleep Aids
◦ Asia Pacific, by OTC Treatment
• Eastern Europe
◦ Eastern Europe, by Country
▪ Russia
▪ Turkey
▪ Rest of Eastern Europe
◦ Eastern Europe, by Non-Pharmacological Therapy
◦ Eastern Europe, by Prescription Sleep Aids
◦ Eastern Europe, by OTC Treatment
• Middle East
◦ Middle East, by Country
▪ UAE
▪ Saudi Arabia
▪ Qatar
▪ Iran
▪ Rest of Middle East
◦ Middle East, by Non-Pharmacological Therapy
◦ Middle East, by Prescription Sleep Aids
◦ Middle East, by OTC Treatment
• Rest of the World
◦ Rest of the World, by Country
▪ South America
▪ Africa
◦ Rest of the World, by Non-Pharmacological Therapy
◦ Rest of the World, by Prescription Sleep Aids
◦ Rest of the World, by OTC Treatment
Major Companies:
Merck & Co., Inc., Meda Consumer Healthcare Inc., Pfizer, Inc., Sanofi, Takeda Pharmaceutical Company Ltd., Pernix Therapeutics, Purdue Pharma.
Years Covered in the Study:
Historic Year: 2016-2017
Base Year:2018
Estimated Year: 2019
Forecast Year: 2028
Objectives of this report:
• To estimate market size for insomnia market on regional and global basis.
• To identify major segments in insomnia market and evaluate their market shares and demand.
• To provide a competitive scenario for the insomnia market with major developments observed by key companies in the historic years.
• To evaluate key factors governing the dynamics of insomnia market with their potential gravity during the
forecast period.
Reasons to Buy This Report:
• Provides niche insights for decision about every possible segment helping in strategic decision making process.
• Market size estimation of the insomnia market on a regional and global basis.
• A unique research design for market size estimation and forecast.
• Identification of major companies operating in the market with related developments
• Exhaustive scope to cover all the possible segments helping every stakeholder in the insomnia market.
Customization:
This study is customized to meet your specific requirements:
• By Segment
• By Sub-segment
• By Region/Country
• Product Specific Competitive Analysis
For more information, contact: sales@quincemarketinsights.com